Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study - PubMed (original) (raw)
doi: 10.1001/archpsyc.61.9.877.
Steven C R Williams, Anthony J Cleare, Michael J Brammer, Nicholas D Walsh, Jieun Kim, Chris M Andrew, Emilio Merlo Pich, Pauline M Williams, Laurence J Reed, Martina T Mitterschiffthaler, John Suckling, Edward T Bullmore
Affiliations
- PMID: 15351766
- DOI: 10.1001/archpsyc.61.9.877
Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study
Cynthia H Y Fu et al. Arch Gen Psychiatry. 2004 Sep.
Abstract
Background: Depression is associated with interpersonal difficulties related to abnormalities in affective facial processing.
Objectives: To map brain systems activated by sad facial affect processing in patients with depression and to identify brain functional correlates of antidepressant treatment and symptomatic response.
Design: Two groups underwent scanning twice using functional magnetic resonance imaging (fMRI) during an 8-week period. The event-related fMRI paradigm entailed incidental affect recognition of facial stimuli morphed to express discriminable intensities of sadness.
Setting: Participants were recruited by advertisement from the local population; depressed subjects were treated as outpatients.
Patients and other participants: We matched 19 medication-free, acutely symptomatic patients satisfying DSM-IV criteria for unipolar major depressive disorder by age, sex, and IQ with 19 healthy volunteers. Intervention After the baseline assessment, patients received fluoxetine hydrochloride, 20 mg/d, for 8 weeks.
Main outcome measures: Average activation (capacity) and differential response to variable affective intensity (dynamic range) were estimated in each fMRI time series. We used analysis of variance to identify brain regions that demonstrated a main effect of group (depressed vs healthy subjects) and a group x time interaction (attributable to antidepressant treatment). Change in brain activation associated with reduction of depressive symptoms in the patient group was identified by means of regression analysis. Permutation tests were used for inference.
Results: Over time, depressed subjects showed reduced capacity for activation in the left amygdala, ventral striatum, and frontoparietal cortex and a negatively correlated increase of dynamic range in the prefrontal cortex. Symptomatic improvement was associated with reduction of dynamic range in the pregenual cingulate cortex, ventral striatum, and cerebellum.
Conclusions: Antidepressant treatment reduces left limbic, subcortical, and neocortical capacity for activation in depressed subjects and increases the dynamic range of the left prefrontal cortex. Changes in anterior cingulate function associated with symptomatic improvement indicate that fMRI may be a useful surrogate marker of antidepressant treatment response.
Similar articles
- Neural responses to happy facial expressions in major depression following antidepressant treatment.
Fu CH, Williams SC, Brammer MJ, Suckling J, Kim J, Cleare AJ, Walsh ND, Mitterschiffthaler MT, Andrew CM, Pich EM, Bullmore ET. Fu CH, et al. Am J Psychiatry. 2007 Apr;164(4):599-607. doi: 10.1176/ajp.2007.164.4.599. Am J Psychiatry. 2007. PMID: 17403973 - Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
Victor TA, Furey ML, Fromm SJ, Öhman A, Drevets WC. Victor TA, et al. Int J Neuropsychopharmacol. 2013 Nov;16(10):2195-208. doi: 10.1017/S146114571300062X. Epub 2013 Jul 1. Int J Neuropsychopharmacol. 2013. PMID: 23809145 Clinical Trial. - Functional magnetic resonance imaging studies of emotional processing in normal and depressed patients: effects of venlafaxine.
Kalin NH, Davidson RJ, Irwin W, Warner G, Orendi JL, Sutton SK, Mock BJ, Sorenson JA, Lowe M, Turski PA. Kalin NH, et al. J Clin Psychiatry. 1997;58 Suppl 16:32-9. J Clin Psychiatry. 1997. PMID: 9430507 - Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies.
Fusar-Poli P, Placentino A, Carletti F, Landi P, Allen P, Surguladze S, Benedetti F, Abbamonte M, Gasparotti R, Barale F, Perez J, McGuire P, Politi P. Fusar-Poli P, et al. J Psychiatry Neurosci. 2009 Nov;34(6):418-32. J Psychiatry Neurosci. 2009. PMID: 19949718 Free PMC article. Review. - Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy.
Outhred T, Hawkshead BE, Wager TD, Das P, Malhi GS, Kemp AH. Outhred T, et al. Neurosci Biobehav Rev. 2013 Sep;37(8):1786-800. doi: 10.1016/j.neubiorev.2013.07.010. Epub 2013 Jul 22. Neurosci Biobehav Rev. 2013. PMID: 23886514 Review.
Cited by
- Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis.
Saberi A, Ebneabbasi A, Rahimi S, Sarebannejad S, Sen ZD, Graf H, Walter M, Sorg C, Camilleri JA, Laird AR, Fox PT, Valk SL, Eickhoff SB, Tahmasian M. Saberi A, et al. Mol Psychiatry. 2024 Oct 15. doi: 10.1038/s41380-024-02780-6. Online ahead of print. Mol Psychiatry. 2024. PMID: 39406999 - Neuroimaging for precision medicine in psychiatry.
Williams LM, Whitfield Gabrieli S. Williams LM, et al. Neuropsychopharmacology. 2024 Jul 22. doi: 10.1038/s41386-024-01917-z. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 39039140 Review. - Altered effective connectivity among face-processing systems in major depressive disorder.
Sheng F, Wang Y, Li R, Li X, Chen X, Zhang Z, Liu R, Zhang L, Zhou Y, Wang G. Sheng F, et al. J Psychiatry Neurosci. 2024 May 1;49(3):E145-E156. doi: 10.1503/jpn.230123. Print 2024 May-Jun. J Psychiatry Neurosci. 2024. PMID: 38692692 Free PMC article. - Neuropsychological Effects of Antidepressants: Translational Studies.
Kamenish K, Robinson ESJ. Kamenish K, et al. Curr Top Behav Neurosci. 2024;66:101-130. doi: 10.1007/7854_2023_446. Curr Top Behav Neurosci. 2024. PMID: 37955824 Review. - The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo design.
Falkenberg I, Bitsch F, Liu W, Matsingos A, Noor L, Vogelbacher C, Yildiz C, Kircher T. Falkenberg I, et al. Trials. 2023 Aug 11;24(1):514. doi: 10.1186/s13063-023-07556-x. Trials. 2023. PMID: 37568215 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical